Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 273

1.

Bcl-3-regulated transcription from major immediate-early promoter of human cytomegalovirus in monocyte-derived macrophages.

Khan KA, Coaquette A, Davrinche C, Herbein G.

J Immunol. 2009 Jun 15;182(12):7784-94. doi: 10.4049/jimmunol.0803800.

2.

Activation of the virus-induced IKK/NF-kappaB signalling axis is critical for the replication of human cytomegalovirus in quiescent cells.

Caposio P, Luganini A, Hahn G, Landolfo S, Gribaudo G.

Cell Microbiol. 2007 Aug;9(8):2040-54. Epub 2007 Apr 5.

PMID:
17419715
4.

Differential expression of the transcription factor NF-kappaB during human mononuclear phagocyte differentiation to macrophages and dendritic cells.

Ammon C, Mondal K, Andreesen R, Krause SW.

Biochem Biophys Res Commun. 2000 Feb 5;268(1):99-105.

PMID:
10652220
6.
8.

Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma.

Thornburg NJ, Pathmanathan R, Raab-Traub N.

Cancer Res. 2003 Dec 1;63(23):8293-301.

9.

Hexamethylene bisacetamide can convert nonpermissive human cells to a permissive state for expressing the major immediate-early genes of human cytomegalovirus by up-regulating NF-kappaB activity.

Kitagawa R, Takahashi Y, Takahashi M, Imazu H, Yasuda M, Sadanari H, Tanaka J.

Virology. 2009 Jan 20;383(2):195-206. doi: 10.1016/j.virol.2008.10.028. Epub 2008 Nov 22.

10.

Targeting the NF-kappaB pathway through pharmacological inhibition of IKK2 prevents human cytomegalovirus replication and virus-induced inflammatory response in infected endothelial cells.

Caposio P, Musso T, Luganini A, Inoue H, Gariglio M, Landolfo S, Gribaudo G.

Antiviral Res. 2007 Mar;73(3):175-84. Epub 2006 Oct 23.

PMID:
17070604
11.

TNF receptor independent activation of the cytomegalovirus major immediate early enhancer in response to transplantation.

Zhang Z, Kim SJ, Varghese T, Thomas G, Hummel M, Abecassis M.

Transplantation. 2008 Apr 15;85(7):1039-45. doi: 10.1097/TP.0b013e318168449c.

PMID:
18408586
12.

BCL-3 and NF-kappaB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages.

Wessells J, Baer M, Young HA, Claudio E, Brown K, Siebenlist U, Johnson PF.

J Biol Chem. 2004 Nov 26;279(48):49995-50003. Epub 2004 Oct 1.

13.

N-acetyl-L-cysteine-induced up-regulation of HIV-1 gene expression in monocyte-derived macrophages correlates with increased NF-kappaB DNA binding activity.

Nottet HS, Moelans II, de Vos NM, de Graaf L, Visser MR, Verhoef J.

J Leukoc Biol. 1997 Jan;61(1):33-9.

PMID:
9000534
14.

NF-kappaB--a potential therapeutic target for inhibition of human cytomegalovirus (re)activation?

Prösch S, Wuttke R, Krüger DH, Volk HD.

Biol Chem. 2002 Oct;383(10):1601-9.

PMID:
12452437
15.

RelB forms transcriptionally inactive complexes with RelA/p65.

Marienfeld R, May MJ, Berberich I, Serfling E, Ghosh S, Neumann M.

J Biol Chem. 2003 May 30;278(22):19852-60. Epub 2003 Mar 25.

16.

Zinc-induced activation of the human cytomegalovirus major immediate-early promoter is mediated by metallothionein and nuclear factor-kappaB.

Kanekiyo M, Itoh N, Kawasaki A, Tanaka J, Nakanishi T, Tanaka K.

Toxicol Appl Pharmacol. 2001 Jun 15;173(3):146-53.

PMID:
11437636
17.

Neutrality of the canonical NF-kappaB-dependent pathway for human and murine cytomegalovirus transcription and replication in vitro.

Benedict CA, Angulo A, Patterson G, Ha S, Huang H, Messerle M, Ware CF, Ghazal P.

J Virol. 2004 Jan;78(2):741-50.

18.

The human cytomegalovirus-encoded receptor US28 increases the activity of the major immediate-early promoter/enhancer.

Boomker JM, The TH, de Leij LF, Harmsen MC.

Virus Res. 2006 Jun;118(1-2):196-200. Epub 2006 Jan 31.

PMID:
16448715
19.

Pentoxifylline promotes replication of human cytomegalovirus in vivo and in vitro.

Staak K, Prosch S, Stein J, Priemer C, Ewert R, Docke WD, Kruger DH, Volk HD, Reinke P.

Blood. 1997 May 15;89(10):3682-90.

20.

Supplemental Content

Support Center